{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:25:49Z","timestamp":1777001149043,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"the National Key Research and Development Program of China","award":["2016YFD0501310"],"award-info":[{"award-number":["2016YFD0501310"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12917-017-0964-0","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T20:45:13Z","timestamp":1486673113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacokinetic and pharmacodynamic modeling of sarafloxacin against avian pathogenic Escherichia coli in Muscovy ducks"],"prefix":"10.1186","volume":"13","author":[{"given":"Yang","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Ping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,10]]},"reference":[{"issue":"3","key":"964_CR1","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.rvsc.2013.07.019","volume":"95","author":"RM Balaje","year":"2013","unstructured":"Balaje RM, Sidhu PK, Kaur G, Rampal S. Mutant prevention concentration and PK-PD relationships of enrofloxacin for Pasteurella multocida in buffalo calves. Res Vet Sci. 2013;95(3):1114\u201324.","journal-title":"Res Vet Sci"},{"issue":"1","key":"964_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jac\/dkg269","volume":"52","author":"K Drlica","year":"2003","unstructured":"Drlica K. The mutant selection window and antimicrobial resistance. J Antimicrob Chemother. 2003;52(1):11\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"964_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","volume":"26","author":"WA Craig","year":"1998","unstructured":"Craig WA. Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26(1):1\u201310. quiz 11-12.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"964_CR4","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1086\/344653","volume":"36","author":"GL Drusano","year":"2003","unstructured":"Drusano GL. Prevention of resistance: a goal for dose selection for antimicrobial agents. Clin Infect Dis. 2003;36 Suppl 1:S42\u201350.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"964_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0034-5288(02)00039-5","volume":"73","author":"PL Toutain","year":"2002","unstructured":"Toutain PL, del Castillo JR, Bousquet-Melou A. The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. Res Vet Sci. 2002;73(2):105\u201314.","journal-title":"Res Vet Sci"},{"issue":"5","key":"964_CR6","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1128\/AAC.00975-10","volume":"55","author":"B Liang","year":"2011","unstructured":"Liang B, Bai N, Cai Y, Wang R, Drlica K, Zhao X. Mutant prevention concentration-based pharmacokinetic\/pharmacodynamic indices as dosing targets for suppressing the enrichment of levofloxacin-resistant subpopulations of Staphylococcus aureus. Antimicrob Agents Chemother. 2011;55(5):2409\u201312.","journal-title":"Antimicrob Agents Chemother"},{"key":"964_CR7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1746-6148-9-126","volume":"9","author":"L Xu","year":"2013","unstructured":"Xu L, Wang H, Yang X, Lu L. Integrated pharmacokinetics\/pharmacodynamics parameters-based dosing guidelines of enrofloxacin in grass carp Ctenopharyngodon idella to minimize selection of drug resistance. BMC Vet Res. 2013;9:126.","journal-title":"BMC Vet Res"},{"issue":"10","key":"964_CR8","doi-asserted-by":"crossref","first-page":"e76917","DOI":"10.1371\/journal.pone.0076917","volume":"8","author":"T Zeng","year":"2013","unstructured":"Zeng T, Jiang X, Li J, Wang D, Li G, Lu L, Wang G. Comparative proteomic analysis of the hepatic response to heat stress in Muscovy and Pekin ducks: insight into thermal tolerance related to energy metabolism. PLoS One. 2013;8(10):e76917.","journal-title":"PLoS One"},{"issue":"2","key":"964_CR9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1637\/10709-110113-ResNote.1","volume":"58","author":"QY Zhuang","year":"2014","unstructured":"Zhuang QY, Wang SC, Li JP, Liu D, Liu S, Jiang WM, Chen JM. A clinical survey of common avian infectious diseases in China. Avian Dis. 2014;58(2):297\u2013302.","journal-title":"Avian Dis"},{"key":"964_CR10","doi-asserted-by":"crossref","unstructured":"La Ragione RM, Sayers AR, Woodward MJ. The role of fimbriae and flagella in the colonization, invasion and persistence of Escherichia coli O78\u2236K80 in the day-old-chick model. Epidemiol Infect. 2000;124(3):351\u2013363.","DOI":"10.1017\/S0950268899004045"},{"issue":"2-3","key":"964_CR11","first-page":"299","volume":"30","author":"M Dho-Moulin","year":"1999","unstructured":"Dho-Moulin M, Fairbrother JM. Avian pathogenic Escherichia coli (APEC). Vet Res. 1999;30(2-3):299\u2013316.","journal-title":"Vet Res"},{"issue":"9-10","key":"964_CR12","first-page":"381","volume":"116","author":"C Ewers","year":"2003","unstructured":"Ewers C, Janssen T, Wieler LH. Avian pathogenic Escherichia coli (APEC). Berl Munch Tierarztl Wochenschr. 2003;116(9-10):381\u201395.","journal-title":"Berl Munch Tierarztl Wochenschr"},{"issue":"1","key":"964_CR13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/ijerph7010089","volume":"7","author":"SM Lutful Kabir","year":"2010","unstructured":"Lutful Kabir SM. Avian colibacillosis and salmonellosis: a closer look at epidemiology, pathogenesis, diagnosis, control and public health concerns. Int J Environ Res Public Health. 2010;7(1):89\u2013114.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"964_CR14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0732-8893(98)00063-7","volume":"32","author":"RN Jones","year":"1998","unstructured":"Jones RN, Erwin ME. In vitro susceptibility testing and quality control parameters for sarafloxacin (a-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry. Quality control study group. Diagn Microbiol Infect Dis. 1998;32(1):55\u201364.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"964_CR15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1365-2885.2001.00348.x","volume":"24","author":"HZ Ding","year":"2001","unstructured":"Ding HZ, Zeng ZL, Fung KF, Chen ZL, Qiao GL. Pharmacokinetics of sarafloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications. J Vet Pharmacol Ther. 2001;24(5):303\u20138.","journal-title":"J Vet Pharmacol Ther"},{"issue":"3","key":"964_CR16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2885.2002.00399.x","volume":"25","author":"FS Aliabadi","year":"2002","unstructured":"Aliabadi FS, Lees P. Pharmacokinetics and pharmacokinetic\/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate. J Vet Pharmacol Ther. 2002;25(3):161\u201374.","journal-title":"J Vet Pharmacol Ther"},{"issue":"3","key":"964_CR17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/sj.jim.7000077","volume":"26","author":"IA Parshikov","year":"2001","unstructured":"Parshikov IA, Freeman JP, Lay Jr JO, Moody JD, Williams AJ, Beger RD, Sutherland JB. Metabolism of the veterinary fluoroquinolone sarafloxacin by the fungus Mucor ramannianus. J Ind Microbiol Biotechnol. 2001;26(3):140\u20134.","journal-title":"J Ind Microbiol Biotechnol"},{"issue":"7","key":"964_CR18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s11259-006-3400-7","volume":"30","author":"AM Haritova","year":"2006","unstructured":"Haritova AM, Rusenova NV, Parvanov PR, Lashev LD, Fink-Gremmels J. Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys. Vet Res Commun. 2006;30(7):775\u201389.","journal-title":"Vet Res Commun"},{"issue":"2","key":"964_CR19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1751-0813.2000.tb10528.x","volume":"78","author":"RD Walker","year":"2000","unstructured":"Walker RD. The use of fluoroquinolones for companion animal antimicrobial therapy. Aust Vet J. 2000;78(2):84\u201390.","journal-title":"Aust Vet J"},{"key":"964_CR20","unstructured":"Products TEAftEoM, Unit VME: Committee for veterinary medicinal products saraflocaxin (Salmonidae) Summary Report (2). 1998, EMEA\/MRL\/349\/98-FINAL February 1998."},{"key":"964_CR21","unstructured":"The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Scientific_Discussion\/veterinary\/000031\/WC500062807.pdf . Accessed 14 Dec 2008."},{"issue":"5","key":"964_CR22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1292\/jvms.61.459","volume":"61","author":"SP Ho","year":"1999","unstructured":"Ho SP, Cheng CF, Wang WS. Pharmacokinetic and depletion studies of sarafloxacin after oral administration to eel (Anguilla anguilla). J Vet Med Sci. 1999;61(5):459\u201363.","journal-title":"J Vet Med Sci"},{"key":"964_CR23","volume-title":"Guide for the care and use of laboratory animals","author":"Institute of Laboratory Animal Research CoLS, Council. NR","year":"1996","unstructured":"Institute of Laboratory Animal Research CoLS, Council. NR. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press; 1996."},{"issue":"3","key":"964_CR24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.rvsc.2012.12.012","volume":"94","author":"J Illambas","year":"2013","unstructured":"Illambas J, Potter T, Cheng Z, Rycroft A, Fishwick J, Lees P. Pharmacodynamics of marbofloxacin for calf pneumonia pathogens. Res Vet Sci. 2013;94(3):675\u201381.","journal-title":"Res Vet Sci"},{"key":"964_CR25","unstructured":"CLSI: Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacterial Isolated from Animals; Approved Standard-Fourth Edition and Supplement, VET01A4E and VET01S2E PA: Clinical and Laboratory Standards Institute 2013"},{"issue":"6","key":"964_CR26","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/jac\/dki136","volume":"55","author":"LL Marcusson","year":"2005","unstructured":"Marcusson LL, Olofsson SK, Komp Lindgren P, Cars O, Hughes D. Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coli. J Antimicrob Chemother. 2005;55(6):938\u201343.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"964_CR27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2885.2008.01027.x","volume":"32","author":"G Elias","year":"2009","unstructured":"Elias G, Lee JS, Hwang MH, Park YS, Cho KH, Kim YH, Park SC. Pharmacokinetics and pharmacokinetic\/pharmacodynamic integration of orbifloxacin in Korean Hanwoo cattle. J Vet Pharmacol Ther. 2009;32(3):219\u201328.","journal-title":"J Vet Pharmacol Ther"},{"issue":"7","key":"964_CR28","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1128\/AAC.01346-08","volume":"53","author":"E Gebru","year":"2009","unstructured":"Gebru E, Lee JS, Chang ZQ, Hwang MH, Cheng H, Park SC. Integration of pharmacokinetic and pharmacodynamic indices of orbifloxacin in beagle dogs after a single intravenous and intramuscular administration. Antimicrob Agents Chemother. 2009;53(7):3024\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"964_CR29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jac\/dkh036","volume":"53","author":"HJ Linde","year":"2004","unstructured":"Linde HJ, Lehn N. Mutant prevention concentration of nalidixic acid, ciprofloxacin, clinafloxacin, levofloxacin, norfloxacin, ofloxacin, sparfloxacin or trovafloxacin for Escherichia coli under different growth conditions. J Antimicrob Chemother. 2004;53(2):252\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"964_CR30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2885.2010.01207.x","volume":"34","author":"L Yuan","year":"2011","unstructured":"Yuan L, Wang R, Sun L, Zhu L, Luo X, Sun J, Fang B, Liu Y. Pharmacokinetics of marbofloxacin in Muscovy ducks (Cairina moschata). J Vet Pharmacol Ther. 2011;34(1):82\u20135.","journal-title":"J Vet Pharmacol Ther"},{"issue":"3","key":"964_CR31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.rvsc.2009.11.009","volume":"88","author":"A Goudah","year":"2010","unstructured":"Goudah A, Hasabelnaby S. Pharmacokinetics, plasma protein binding and bioavailability of moxifloxacin in Muscovy ducks after different routes of administration. Res Vet Sci. 2010;88(3):507\u201311.","journal-title":"Res Vet Sci"},{"issue":"11","key":"964_CR32","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1099\/0022-1317-49-11-943","volume":"49","author":"P Lees","year":"2000","unstructured":"Lees P, Aliabadi FS. Rationalising dosage regimens of antimicrobial drugs: a pharmacological perspective. J Med Microbiol. 2000;49(11):943\u20135.","journal-title":"J Med Microbiol"},{"issue":"3-4","key":"964_CR33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.vetmic.2013.12.021","volume":"171","author":"MG Papich","year":"2014","unstructured":"Papich MG. Pharmacokinetic-pharmacodynamic (PK-PD) modeling and the rational selection of dosage regimes for the prudent use of antimicrobial drugs. Vet Microbiol. 2014;171(3-4):480\u20136.","journal-title":"Vet Microbiol"},{"issue":"Pt 10","key":"964_CR34","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1099\/jmm.0.028654-0","volume":"60","author":"E Gebru","year":"2011","unstructured":"Gebru E, Choi MJ, Lee SJ, Damte D, Park SC. Mutant-prevention concentration and mechanism of resistance in clinical isolates and enrofloxacin\/marbofloxacin-selected mutants of Escherichia coli of canine origin. J Med Microbiol. 2011;60(Pt 10):1512\u201322.","journal-title":"J Med Microbiol"},{"issue":"11","key":"964_CR35","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1128\/AAC.00156-07","volume":"51","author":"A Ferran","year":"2007","unstructured":"Ferran A, Dupouy V, Toutain PL, Bousquet-Melou A. Influence of inoculum size on the selection of resistant mutants of Escherichia coli in relation to mutant prevention concentrations of marbofloxacin. Antimicrob Agents Chemother. 2007;51(11):4163\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"964_CR36","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/jac\/dkm360","volume":"60","author":"PL Toutain","year":"2007","unstructured":"Toutain PL, Bousquet-Melou A, Martinez M. AUC\/MIC: a PK\/PD index for antibiotics with a time dimension or simply a dimensionless scoring factor? J Antimicrob Chemother. 2007;60(6):1185\u20138.","journal-title":"J Antimicrob Chemother"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-017-0964-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T06:13:51Z","timestamp":1498371231000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-017-0964-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["964"],"URL":"https:\/\/doi.org\/10.1186\/s12917-017-0964-0","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]},"article-number":"47"}}